Literature DB >> 2769800

Increase in cathepsin D activity in rat brain in aging.

A Kenessey1, M Banay-Schwartz, T DeGuzman, A Lajtha.   

Abstract

Cathepsin D-like activity in homogenates of five brain areas of 3-month-old and 24-month-old Fischer 344 rats was measured. With hemoglobin as substrate at pH 3.2, more than 90% of the activity was inhibited by pepstatin. In each area studied, activity was more than twice as high in the old rat brain: 140-160% higher in the cortex, cerebellum, pons-medulla, and striatum and 90-100% higher in the hippocampus and spinal cord. The greatly increased metabolic capacity in the absence of an increase in protein turnover may have a role in age-related pathological degeneration in the brain.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2769800     DOI: 10.1002/jnr.490230412

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  14 in total

1.  Suppression of cathepsins B and L causes a proliferation of lysosomes and the formation of meganeurites in hippocampus.

Authors:  E Bednarski; C E Ribak; G Lynch
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Calpain activity in adult and aged human brain regions.

Authors:  M Banay-Schwartz; T DeGuzman; M Palkovits; A Lajtha
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

3.  Structure-based subsite specificity mapping of human cathepsin D using statine-based inhibitors.

Authors:  P Majer; J R Collins; S V Gulnik; J W Erickson
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

4.  Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha.

Authors:  L P Deiss; H Galinka; H Berissi; O Cohen; A Kimchi
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

Review 5.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

6.  Effects of brief starvation on brain protease activity.

Authors:  A Kenessey; M Banay-Schwartz; T De Guzman; A Lajtha
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

7.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Authors:  E T Baldwin; T N Bhat; S Gulnik; M V Hosur; R C Sowder; R E Cachau; J Collins; A M Silva; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Alteration of protease levels in different brain areas of suicide victims.

Authors:  M Banay-Schwartz; T DeGuzman; G Faludi; A Lajtha; M Palkovits
Journal:  Neurochem Res       Date:  1998-07       Impact factor: 3.996

Review 9.  The degradation of amyloid beta as a therapeutic strategy in Alzheimer's disease and cerebrovascular amyloidoses.

Authors:  Laura Morelli; Ramiro Llovera; Sandra Ibendahl; Eduardo M Castaño
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

10.  Calpain II activity and calpastatin content in brain regions of 3- and 24-month-old rats.

Authors:  A Kenessey; M Banay-Schwartz; T DeGuzman; A Lajtha
Journal:  Neurochem Res       Date:  1990-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.